![Genes | Free Full-Text | Low RIN Value for RNA-Seq Library Construction from Long-Term Stored Seeds: A Case Study of Barley Seeds Genes | Free Full-Text | Low RIN Value for RNA-Seq Library Construction from Long-Term Stored Seeds: A Case Study of Barley Seeds](https://pub.mdpi-res.com/genes/genes-11-01190/article_deploy/html/images/genes-11-01190-g001.png?1607056727)
Genes | Free Full-Text | Low RIN Value for RNA-Seq Library Construction from Long-Term Stored Seeds: A Case Study of Barley Seeds
![Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy](https://www.cell.com/cms/asset/fb282b4e-87cf-4544-b03a-7510b259f329/fx1.jpg)
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy
![Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X](https://pbs.twimg.com/media/FOoDi-JVQAIZcbW.jpg:large)
Moderna on X: "Additionally, a therapeutic vaccine (mRNA-1195) against long- term EBV sequelae, such as #MultipleSclerosis (MS) and post-transplant lymphoproliferative disease (PTLD) is in preclinical development. https://t.co/88ehVxosyT" / X
![Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-25134-0/MediaObjects/41598_2022_25134_Fig1_HTML.png)
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports
![Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-25134-0/MediaObjects/41598_2022_25134_Fig5_HTML.png)
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex | Scientific Reports
![Frontiers | mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine Frontiers | mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine](https://www.frontiersin.org/files/Articles/1020844/fimmu-13-1020844-HTML/image_m/fimmu-13-1020844-g006.jpg)
Frontiers | mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
![Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_714096_16528853118824333.jpg)
Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients
![IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery](https://www.mdpi.com/ijms/ijms-24-01404/article_deploy/html/images/ijms-24-01404-g001-550.jpg)
IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
![Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00861-4/MediaObjects/41392_2021_861_Fig4_HTML.png)
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates | Signal Transduction and Targeted Therapy
![Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ](https://www.bmj.com/content/bmj/378/bmj-2022-071502/F1.medium.jpg)
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
![FXR1P Limits Long-Term Memory, Long-Lasting Synaptic Potentiation, and De Novo GluA2 Translation - ScienceDirect FXR1P Limits Long-Term Memory, Long-Lasting Synaptic Potentiation, and De Novo GluA2 Translation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124714008821-fx1.jpg)
FXR1P Limits Long-Term Memory, Long-Lasting Synaptic Potentiation, and De Novo GluA2 Translation - ScienceDirect
![A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21037-2/MediaObjects/41467_2021_21037_Fig1_HTML.png)